Press release
Multiple Sclerosis Pipeline Drugs 2024 | TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, Ge
Find out more about Multiple Sclerosis treatment drugs @ Drugs for Multiple Sclerosis Treatment [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from Multiple Sclerosis Pipeline Report
* August 2024:- Hoffmann-La Roche- A Single Arm, Open Label Multicentre Extension Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Multiple Sclerosis Previously Enrolled In A F. Hoffmann-La Roche Sponsored Ocrelizumab Phase IIIb/IV Clinical Trials. This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who were previously enrolled in a F. Hoffmann-La Roche (Roche) sponsored ocrelizumab phase IIIb/IV trial (i.e. the Parent, P-trial).
* August 2024:- Novartis Pharmaceuticals- Open-Label Rater-Blind Randomized Multi-Center Parallel-Arm Active- Comparator Study to Assess the Efficacy and Tolerability of Ofatumumab 20mg SC Monthly vs. First Line DMT - Physician's Choice in the Treatment of Newly Diagnosed RMS. This study will compare ofatumumab vs. European approved platform first line self-administered disease modifying therapy (DMT) in newly diagnosed MS patients
* DelveInsight's Multiple Sclerosis pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for Multiple Sclerosis treatment.
* The leading Multiple Sclerosis Companies working in the market include TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, and others.
* Promising Multiple Sclerosis Therapies in the various stages of development include 11C-BMS-986196, ofatumumab, Fingolimod, Siponimod, elezanumab, Alemtuzumab, Tecfidera, and others
Request a sample and discover the recent advances in Multiple Sclerosis treatment drugs @ Multiple Sclerosis Pipeline Outlook Report [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Multiple Sclerosis Emerging Drugs Profile
* Ublituximab: TG Therapeutics
* IMU-838: Immunic
* ATA188: Atara Biotherapeutics
* ANK-700: ANOKION
Multiple Sclerosis Therapeutics Assessment
There are approx. 100+ key Multiple Sclerosis companies which are developing the therapies for Multiple sclerosis. The Multiple Sclerosis companies which have their Multiple sclerosis drug candidates in the most advanced stage, i.e. preregistration include, TG Therapeutics.
DelveInsight's Multiple Sclerosis pipeline report covers around 100+ products under different phases of clinical development like
* Late stage products (Phase III)
* Mid-stage products (Phase II)
* Early-stage product (Phase I) along with the details of
* Pre-clinical and Discovery stage candidates
* Discontinued & Inactive candidates
* Route of Administration
Learn more about the emerging Multiple Sclerosis pipeline therapies @ Multiple Sclerosis Clinical Trials [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Multiple sclerosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.
* Oral
* Parenteral
* Intravenous
* Subcutaneous
* Topical.
* Molecule Type
Multiple Sclerosis Products have been categorized under various Molecule types such as
* Monoclonal Antibody
* Peptides
* Polymer
* Small molecule
* Gene therapy
* Product Type
Multiple Sclerosis Companies
TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, and others
Dive deep into rich insights for new drugs for Multiple Sclerosis Treatment, visit @ Multiple Sclerosis Drugs [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Multiple Sclerosis Pipeline Report
* Coverage- Global
* Multiple Sclerosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Multiple Sclerosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
* Multiple Sclerosis Companies- TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, and others
* Multiple Sclerosis Therapies- 11C-BMS-986196, ofatumumab, Fingolimod, Siponimod, elezanumab, Alemtuzumab, Tecfidera, and others
For further information on the Multiple Sclerosis Pipeline Therapeutics, reach out @ Multiple Sclerosis Treatment Drugs [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Multiple sclerosis: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Multiple sclerosis - DelveInsight's Analytical Perspective
* Late Stage Products (Preregistration)
* Ublituximab: TG Therapeutics
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* EHP 101: Emerald Health Pharmaceuticals
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* ASLAN 003: ASLAN Pharmaceuticals
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Lucid MS: FSD Pharma
* Drug profiles in the detailed report.....
* Inactive Products
* Multiple sclerosis Key Companies
* Multiple sclerosis Key Products
* Multiple sclerosis- Unmet Needs
* Multiple sclerosis- Market Drivers and Barriers
* Multiple sclerosis- Future Perspectives and Conclusion
* Multiple sclerosis Analyst Views
* Multiple sclerosis Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=multiple-sclerosis-pipeline-drugs-2024-tg-therapeutics-immunic-atara-biotherapeutics-anokion-imstem-biotechnology-merck-serono-cinnagen-immune-response-biopharma-inc-clene-nanomedicine-ge]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiple Sclerosis Pipeline Drugs 2024 | TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, Ge here
News-ID: 3620170 • Views: …
More Releases from ABNewswire
Veterans National Property Services Expands Lake Magdalene, FL Offerings to Incl …
Lake Magdalene, FL - Veterans National Property Services [https://vnpsroofing.com/service-area/lake-magdalene-fl/gutter-services/] has expanded its exterior services to include gutter repair in Lake Magdalene, FL. The veteran-owned roofing contractor, known for projects across the Greater Tampa Bay Area, is responding to growing homeowner demand for solutions to gutter problems caused by Florida's heat, humidity, and seasonal heavy rain.
The new service addresses the full spectrum of gutter needs-from installation and repair to replacement, cleaning,…
Stella Crispo Releases New Single and Promo Video 'All of Me' Out Now
October 22, 2025 - New Jersey/New York - Singer songwriter, Stella Crispo, is excited to announce the release of her new song 'All of Me.' Written several years ago and now arranged as a dance song, 'All of Me' is about true love that begins in the imagination hoping to become a reality. Stella believes her song is being released at the perfect time. "We are living in a world…
Synergy (NASDAQ: SNYR) Surges: FOCUSfactor Registered Expansion - Kroger (NYSE: …
Shares of Synergy CHC Corp. (NASDAQ: SNYR) climbed 13.86% to $2.88 in early trading on strong volume following news of an expanded retail rollout for its flagship FOCUSfactor Registered supplements and Focus + Energy functional beverages. The expansion brings new distribution through Kroger Co. (NYSE: KR), Wakefern's ShopRite Ltd. (OTC: SRHGF), and PriceSmart Inc. (NASDAQ: PSMT)-broadening the brand's footprint across the U.S., Canada, and Latin America.
In Canada, Fortinos, part of…
Fiberglass Fabric Market 2025 Trends: Challenges and Opportunities with Top Key …
The Fiberglass Market continues to expand, driven by its high strength-to-weight ratio, corrosion resistance, and versatility across industries such as construction, automotive, wind energy, and aerospace. Key players like Owens Corning, Saint-Gobain, Nippon Electric Glass, and Jushi Group are investing in advanced composites and sustainable manufacturing to meet growing global demand.
The Fiberglass fabric market is projected to reach USD 13.17 billion by 2029 from USD 9.39 billion in 2024, at…
More Releases for Multiple
Mango AI's Multiple Face Swap Video Tool Changes Multiple Faces Instantly
In today's digital world, creating eye-catching and unique content is essential for standing out. The ability to swap multiple faces in a single video opens up creative possibilities, whether for personalized content, comedy or parody videos, or engaging social media posts. Mango AI, developed by Mango Animate, is excited to announce the launch of its advanced multiple face swap video (https://mangoanimate.com/ai/multiple-face-swap-video) tool, which is designed to simplify the creation of…
Multiple Sclerosis Drugs Market
Global Multiple Sclerosis Drugs Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.
Get a Sample Copy of the Report at - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100386
Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as progressive brain and spinal cord atrophy and neuroaxonal…
Massive Multiple Input Multiple Output (MIMO) Market May Set New Growth Story
A Latest intelligence report published by MR Forecast with title "Global Massive Multiple Input Multiple Output (MIMO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Massive Multiple Input Multiple Output (MIMO) market. This report provides a detailed overview of key factors in the Global Massive Multiple Input Multiple Output (MIMO) Market and factors such as driver, restraint, past and current trends,…
Multiple Sclerosis Drugs Market - Progressing Towards a Cure: Advancing Multiple …
Newark, New Castle, USA: The "Multiple Sclerosis Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiple Sclerosis Drugs Market: https://www.growthplusreports.com/report/multiple-sclerosis-drugs-market/7983
This latest report researches the industry structure,…
Multiple Sclerosis Drugs Market - Empowering Resilience, Embracing Possibilities …
Newark, New Castle, USA - new report, titled Multiple Sclerosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Multiple Sclerosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Multiple Sclerosis Drugs market. The report offers an overview of…
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)…
